| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3960867
[patent_doc_number] => 05900420
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-04
[patent_title] => 'Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine'
[patent_app_type] => 1
[patent_app_number] => 9/099900
[patent_app_country] => US
[patent_app_date] => 1998-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2781
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/900/05900420.pdf
[firstpage_image] =>[orig_patent_app_number] => 099900
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/099900 | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine | Jun 17, 1998 | Issued |
Array
(
[id] => 4098931
[patent_doc_number] => 06048843
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Topical composition containing amino acid in combination with either interferon of thymidine derivatives for treating viral or inflammation diseases'
[patent_app_type] => 1
[patent_app_number] => 9/043657
[patent_app_country] => US
[patent_app_date] => 1998-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2419
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048843.pdf
[firstpage_image] =>[orig_patent_app_number] => 043657
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/043657 | Topical composition containing amino acid in combination with either interferon of thymidine derivatives for treating viral or inflammation diseases | Jun 15, 1998 | Issued |
Array
(
[id] => 4223742
[patent_doc_number] => 06011040
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine'
[patent_app_type] => 1
[patent_app_number] => 9/095572
[patent_app_country] => US
[patent_app_date] => 1998-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2193
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/011/06011040.pdf
[firstpage_image] =>[orig_patent_app_number] => 095572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/095572 | Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine | Jun 10, 1998 | Issued |
Array
(
[id] => 4239544
[patent_doc_number] => 06090827
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Pharmaceutical formulation of omeprazole'
[patent_app_type] => 1
[patent_app_number] => 9/077717
[patent_app_country] => US
[patent_app_date] => 1998-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3787
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090827.pdf
[firstpage_image] =>[orig_patent_app_number] => 077717
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/077717 | Pharmaceutical formulation of omeprazole | Jun 7, 1998 | Issued |
| 09/093128 | TREATMENT OF RESPIRATORY DISEASES UTILIZING ALPHA-TOCOPHERYL-PHOSPHOCHOLINE | Jun 7, 1998 | Issued |
Array
(
[id] => 4082928
[patent_doc_number] => 06054488
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Medicinal aerosol formulations of formoterol'
[patent_app_type] => 1
[patent_app_number] => 9/088871
[patent_app_country] => US
[patent_app_date] => 1998-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3713
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054488.pdf
[firstpage_image] =>[orig_patent_app_number] => 088871
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/088871 | Medicinal aerosol formulations of formoterol | Jun 1, 1998 | Issued |
Array
(
[id] => 3987018
[patent_doc_number] => 05985282
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Herbal appetite suppressant and weight loss composition'
[patent_app_type] => 1
[patent_app_number] => 9/088252
[patent_app_country] => US
[patent_app_date] => 1998-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 4695
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985282.pdf
[firstpage_image] =>[orig_patent_app_number] => 088252
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/088252 | Herbal appetite suppressant and weight loss composition | May 31, 1998 | Issued |
Array
(
[id] => 3956636
[patent_doc_number] => 05935994
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Nutritionally balanced dermal composition and method'
[patent_app_type] => 1
[patent_app_number] => 9/087594
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1974
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935994.pdf
[firstpage_image] =>[orig_patent_app_number] => 087594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/087594 | Nutritionally balanced dermal composition and method | May 28, 1998 | Issued |
Array
(
[id] => 3924050
[patent_doc_number] => 05914330
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-22
[patent_title] => 'Nephroprotective pharmaceutical composition and use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/084916
[patent_app_country] => US
[patent_app_date] => 1998-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2345
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/914/05914330.pdf
[firstpage_image] =>[orig_patent_app_number] => 084916
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/084916 | Nephroprotective pharmaceutical composition and use thereof | May 27, 1998 | Issued |
Array
(
[id] => 3941088
[patent_doc_number] => 05981586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Methods for treating proliferative and inflammatory skin diseases'
[patent_app_type] => 1
[patent_app_number] => 9/084037
[patent_app_country] => US
[patent_app_date] => 1998-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6341
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981586.pdf
[firstpage_image] =>[orig_patent_app_number] => 084037
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/084037 | Methods for treating proliferative and inflammatory skin diseases | May 21, 1998 | Issued |
Array
(
[id] => 4304725
[patent_doc_number] => 06251920
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Prevention and treatment of cardiovascular pathologies'
[patent_app_type] => 1
[patent_app_number] => 9/082643
[patent_app_country] => US
[patent_app_date] => 1998-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33847
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251920.pdf
[firstpage_image] =>[orig_patent_app_number] => 082643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/082643 | Prevention and treatment of cardiovascular pathologies | May 20, 1998 | Issued |
Array
(
[id] => 4156408
[patent_doc_number] => 06103722
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Ischemic preconditioning'
[patent_app_type] => 1
[patent_app_number] => 9/080665
[patent_app_country] => US
[patent_app_date] => 1998-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12789
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103722.pdf
[firstpage_image] =>[orig_patent_app_number] => 080665
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/080665 | Ischemic preconditioning | May 17, 1998 | Issued |
Array
(
[id] => 3998306
[patent_doc_number] => 05922769
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II'
[patent_app_type] => 1
[patent_app_number] => 9/029371
[patent_app_country] => US
[patent_app_date] => 1998-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3778
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922769.pdf
[firstpage_image] =>[orig_patent_app_number] => 029371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029371 | Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II | May 12, 1998 | Issued |
| 09/076711 | COMBINED ESTROGEN AND ANTIESTROGEN THERAPY | May 11, 1998 | Pending |
Array
(
[id] => 4107680
[patent_doc_number] => 06022852
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Pharmaceutical composition containing cyclosporin A'
[patent_app_type] => 1
[patent_app_number] => 9/076175
[patent_app_country] => US
[patent_app_date] => 1998-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2970
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022852.pdf
[firstpage_image] =>[orig_patent_app_number] => 076175
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/076175 | Pharmaceutical composition containing cyclosporin A | May 10, 1998 | Issued |
Array
(
[id] => 3955724
[patent_doc_number] => 05935933
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Anticonvulsant derivatives useful in treating neuropathic pain'
[patent_app_type] => 1
[patent_app_number] => 9/073158
[patent_app_country] => US
[patent_app_date] => 1998-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2432
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935933.pdf
[firstpage_image] =>[orig_patent_app_number] => 073158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/073158 | Anticonvulsant derivatives useful in treating neuropathic pain | May 4, 1998 | Issued |
| 09/071436 | METHOD FOR ENHANCING FEMALE SEXUAL RESPONSE AND AN OINTMENT THEREFOR | Apr 30, 1998 | Issued |
Array
(
[id] => 4066490
[patent_doc_number] => 06008254
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Method of treating skin disorders with high-strength tretinoin'
[patent_app_type] => 1
[patent_app_number] => 9/071017
[patent_app_country] => US
[patent_app_date] => 1998-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4381
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008254.pdf
[firstpage_image] =>[orig_patent_app_number] => 071017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/071017 | Method of treating skin disorders with high-strength tretinoin | Apr 30, 1998 | Issued |
| 08/981779 | COMPOUNDS USEFUL IN THE TREATMENT OF NEUROFIBROMATOSIS | Apr 29, 1998 | Abandoned |
| 09/066973 | FUNGICIDAL COMPOUNDS | Apr 27, 1998 | Issued |